Profiel
Sarah C.
DiSalvatore worked as Vice President-Clinical Operations at Beacon Therapeutics (USA), Inc. from 2021 to 2023.
Prior to that, she worked as Associate Vice President-Clinical Operations at Rocket Pharmaceuticals, Inc.
Eerdere bekende functies van Sarah DiSalvatore
| Bedrijven | Functie | Einde |
|---|---|---|
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-04-2023 |
| ROCKET PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. | Health Technology |
